BLOG-IMAGES-041017-02 (1).jpg

elandas blog

New Drug Success Can Hinge on Market Access Predictions

In today’s high-stakes world of drug launches, top pharma teams are discovering that even before new products hit the market the ultimate secret weapon in their success arsenal can be the intelligence being gathered and effectively shared by members of their own team day-by-day.  

With millions of dollars and lives at stake- setting the stage for a new drug’s success trajectory is crucial in the early stages. And certainly more important than ever, is access to decision influencing data that can enable a launch team to course correct its strategy in real time.

Just because you are in the pre-launch stage of a new drug’s lifecycle it doesn’t mean you have settle for being left in the dark when it comes to future market access visibility. Collecting projection information via your team in the field can actually be a very coordinated, precise, and yes accurate process. One that yields valuable insights that are impactful when it comes to making the appropriate shifts in your brand’s strategy leading up to launch.

How purpose-built business intelligence tools can help: 

With the right pharma-specific business intelligence tools, you don’t have to be caught flat-footed when it comes to having a clear view of your product’s projected market access. Or, end up in a people hours eating death spiral of Excel sheet updates that for many teams used to look something like the following. Pharma X Company Field Director, David, had a big spreadsheet and would call 50 plus account managers responsible for a particular set of insurance companies, and ask them, “Okay, what they are telling you about how this drug will be covered?”  Sometimes he would reach out to them via email too. It was a very manual process that he would have to refresh every 14 days as it’s critical having all of this information up-to-date during Pre-Launch, and it ate up 80% of David’s time. 

That’s quite a bit of effort for something that with the right technology solution can be done with a click of a report button. Even better, the information is both highly accurate because of built-in access data validation which is key to making accurate predictions, and it’s able to be locked down so that only approved stakeholders within an organization have access. Key to all of this is finding a system that offers the kind of high configurability that can be tweaked to meet your team’s ongoing needs for new and expanded insights.


read more

Gaining Altitude in Your View Can Boost Pharma Launch Success

In today’s ever more complex and high stakes pharmaceutical selling environment having a united commercial strategy for gaining information can be the difference between being agile as an organization or not being nimble enough to compete. 

read more

Responding to Today's Drug Launch Challenges

More informed launch planning and execution, and an increased ability to assess and adapt go to market strategies in the early stages of a pharmaceutical product hitting the market can prove critical to its early success. 

The ability to nimbly assess and act can ultimately become a huge factor in determining whether a product reaches its full potential or fizzles instead.

Here we take a look at how your team can best position itself for the win when it comes to launch success.

read more

Product Launches – Does Your Approach Need an Overhaul?

Getting a product to launch on time and with success is harder than ever for today’s life sciences marketers. You must have the right tools to keep up. Problem is, many are using old strategies to win a new game. Using an outdated approach will ensure your launch lacks the speed and flexibility needed to beat the competition.

read more